Articles From: Bill Gross Leaves Pimco for Janus -- 5th Update to Boeing, Etihad Airways Unveil Livery of Airline's First 787-9 Dreamliner


2014/9/26
By Kirsten Grind And Michael Calia Legendary bond investor Bill Gross has left Pacific Investment Management Co., the firm he founded in 1971, following a year of heavy outflows from his flagship bond fund and a fight with his former chief executive and heir apparent.
Sign-up for Bill Gross Leaves Pimco for Janus -- 5th Update investment picks
By Daisuke Wakabayashi In response to reports that its largest iPhone is bending in the pockets of users, Apple Inc. said the cases of an iPhone warping through normal use are "extremely rare." Since going on sale Friday, Apple (AAPL) said only nine customers have contacted the company about a bent iPhone 6 Plus--the larger and more expensive of its two new iPhones.
Sign-up for Apple defends against complaints of bending iPhones investment picks
2014/9/28
BERLIN--The sale of German utility RWE AG's (RWEOY, RWE.XE) oil and gas unit, Dea, to Russian Mikhail Fridman has run into problems with the United Kingdom.
Sign-up for RWE's Sale of Dea Unit Hits Snag in U.K. investment picks
2014/9/28
By Wayne Ma AirAsia Bhd.
Sign-up for AirAsia: Establishes Unit For Aircraft Leasing Services investment picks
2014/9/28
By Ryan Knutson Americans can easily take their phone number along when switching carriers.
Sign-up for Phone Database Transfer Draws Lawmakers' Scrutiny investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022661-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/28/11G022661/20130207-eca_200-473944305185.jpg CALGARY, AB--(Marketwired - September 28, 2014) - Encana Corporation (TSX: ECA) (NYSE: ECA) will hold a conference call before the North American public markets open Monday, September 29, 2014.
Sign-up for Encana to Hold Conference Call Before North American Markets Open on Monday, September 29, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970137001&sourceType=1 http://www.ccnmatthews.com/logos/20100511-GOBI%20LARGE.gif HONG KONG, CHINA --
Sign-up for SouthGobi Resources Announces the Completion of the Construction of a Paved Coal Highway to Mongolia-China Border investment picks
2014/9/28
By Robb M.
Sign-up for Australia's ANZ to Sell Stake in Saigon Securities investment picks
SHANGHAI , Sept.
Sign-up for Ctrip To Purchase Certain Premises In Sky SOHO investment picks
Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline TOKYO and SAN DIEGO , Sept.
Sign-up for Daiichi Sankyo to Acquire Ambit Biosciences investment picks
2014/9/28
By Leslie Scism Maurice R.
Sign-up for Hank Greenberg Challenges AIG Bailout investment picks
2014/9/28
By Chase Gummer BERLIN--The sale of German utility RWE AG's (RWEOY, RWE.XE) oil and gas unit, Dea, to Russian Mikhail Fridman has run into problems with the United Kingdom.
Sign-up for RWE's Sale of Its Dea Unit Hits Snag in U.K. -- Update investment picks
2014/9/28
In the news release, NiSource Inc. to Form Natural Gas Pipeline, Midstream & Storage Master Limited Partnership, issued earlier today by NiSource Inc. over PR Newswire, we are advised by the company that the second paragraph, should read: NiSource expects the MLP to file a registration statement with the Securities and Exchange Commission ("SEC") tomorrow.
Sign-up for /C O R R E C T I O N -- NiSource Inc./ investment picks
By Russ Britt, MarketWatch The ever-bankable Denzel Washington helped Hollywood inch toward closing its year-to-year box-office deficit as his latest film, "The Equalizer," scored $35 million in U.S. theaters over the weekend and led all films in revenue.
Sign-up for UPDATE: Denzel Washington's new movie is a box-office 'equalizer' investment picks
By Russ Britt, MarketWatch The ever-bankable Denzel Washington helped Hollywood inch toward closing its year-to-year box-office deficit as his latest film, "The Equalizer," scored $35 million in U.S. theaters over the weekend and led all films in revenue.
Sign-up for Denzel Washington's new movie is a box-office 'equalizer' investment picks
2014/9/28
-- Separation would result in two highly focused, premier energy infrastructure companies: a fully regulated natural gas and electric utilities company (NiSource), and a pure-play natural gas pipeline, midstream and storage company (Columbia Pipeline Group) --
Sign-up for NiSource Announces Plan to Separate Into Two Publicly Traded Companies investment picks
2014/9/28
BERLIN--The sale of German utility RWE AG's (RWEOY, RWE.XE) oil and gas unit, Dea, to Russian oligarch Michail Fridman has run into problems with the United Kingdom, according to German magazine Der Spiegel.
Sign-up for RWE's Sale of Its Dea Unit Hits Snag in U.K. -- Report investment picks
2014/9/28
By Damian Paletta And Kristina Peterson President Barack Obama said that U.S. intelligence officials "underestimated what had been taking place in Syria," and that several years of political chaos in the country had created an environment for Islamic State to thrive in Syria and Iraq.
Sign-up for Obama Says U.S. Intelligence Underestimated Developments in Syria investment picks
2014/9/28
National Bank Invests an Additional $1 million in Inspiring Projects for Young People Canada NewsWire Thousands of youths Hundreds of ideas and projects brought to life Building a better community MONTREAL , Sept.
Sign-up for National Bank Invests an Additional $1 million in Inspiring Projects for Young People investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company’s proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, were presented in a poster discussion session at the 2014 Congress of the European Society for Medical Oncology (ESMO) in Madrid, Spain.
Sign-up for Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress investment picks
MADRID and REDWOOD CITY, Calif, Sept.
Sign-up for OncoMed's Demcizumab Phase 1b Clinical Trials Show Encouraging Safety and Anti-Tumor Activity at ESMO investment picks
2014/9/28
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Investors will pick through several economic reports this week, but attention is likely to focus on jobs numbers due on Friday.
Sign-up for UPDATE: Investors likely to focus on jobs data investment picks
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trade in Monday's session are Alibaba Group Holding Ltd., Cal-Maine Foods Inc. and Cintas Corp.
Sign-up for UPDATE: Alibaba, Cal-Maine, expected to see active trade investment picks
NANJING, China, Sept.
Sign-up for Tuniu Expands Network of Regional Service Centers investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA ® (pembrolizumab) – the company’s anti-PD-1 therapy – in PD-L1 positive, advanced gastric cancer.
Sign-up for Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014 investment picks
ZUG, Switzerland, Sept.
Sign-up for Coca-Cola HBC AG Named Industry Leader in the 2014 Dow Jones Sustainability Index investment picks
Clovis Oncology (NASDAQ:CLVS) today announced preliminary Phase 2 results from the ARIEL2 ( A ssessment of R ucaparib I n Ovarian Canc e r Tria l ) study and updated results from the ongoing Phase 1/2 monotherapy study of rucaparib.
Sign-up for Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy investment picks
2014/9/28
New 'Facets of Abu Dhabi' livery reminiscent of desert landscape, inspired by culture of the United Arab Emirates Abu Dhabi-based airline one of the world's largest 787 customers EVERETT, Wash.
Sign-up for Boeing, Etihad Airways Unveil Livery of Airline's First 787-9 Dreamliner investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Bill Gross Leaves Pimco for Janus -- 5th Update to Boeing, Etihad Airways Unveil Livery of Airline's First 787-9 Dreamliner
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices